CURLF - Cannabis provider Tilray stock has sunk 40% over the past 30 days. Is now the time to buy?

Shares of Tilray (TLRY) have lost 40% of their value over the past 30 days, despite recent signs of progress towards the federal legalization of cannabis in the US. Is now a good time to buy? Weed stocks have been volatile for months, bobbing up and down with the news flow on Congressional efforts to legalize the drug on the federal level. While the product has been legalized in many states for medical and/or recreational use, it is still classified as a controlled substance by the US Drug Enforcement Agency. Tilray’s stock has slid largely in tandem with its peers lately. As of April 28, shares of Canopy Growth (CGC) had plunged 37% over the previous 30 days. Meanwhile, Sundial Growers (SNDL) retreated 38%, Aurora Cannabis (ACB) fell 32% and Cronos Group (CRON) declined 29%. Curaleaf (OTCPK:CURLF) has performed the best, sliding only 9%. Despite the overall downward trend, Tilray

For further details see:

Cannabis provider Tilray stock has sunk 40% over the past 30 days. Is now the time to buy?